TEK and neoplasm: One mechanism of tumor resistance or recurrence following anti-angiogenic therapy in patients is attributed to the increased recruitment and infiltration of Tie2-expressing macrophages into the tumor in response to apoptosis, necrosis, and hypoxia after vascular regression [66].